PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
J Clin Oncol
; 39(26): 2903-2913, 2021 09 10.
Article
in En
| MEDLINE
| ID: mdl-34133211
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxonic Acid
/
Stomach Neoplasms
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Tegafur
/
Neoadjuvant Therapy
/
Esophagogastric Junction
/
Docetaxel
/
Oxaliplatin
/
Gastrectomy
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Clin Oncol
Year:
2021
Document type:
Article